Cox’s proportional hazard model built including the most important biological variables revealed that IGF1R expression represented an independent prognostic factor of TTFT in early stage CLL considering either all CLL patients (Table 2) or only IGHV-M (Table 3). This evidence concerns the gene IGF1R and B-cell chronic lymphocytic leukemia.